Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.

doi:10.1002/cncr.35431

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.

Cancer - 15 Oct 2024

Labrador Jorge, Martínez-Cuadrón David, Boluda Blanca, Serrano Josefina, Gil Cristina, Pérez-Simón José A, Bernal Teresa, Bergua Juan M, Martínez-López Joaquín, Rodríguez-Medina Carlos, Vidriales María B, García-Boyero Raimundo, Algarra Lorenzo, Polo Marta, Sayas María J, Tormo Mar, Alonso-Domínguez Juan M, Herrera Pilar, Lavilla Esperanza, Ramos Fernando, Amigo María L, Vives-Polo Susana, Rodríguez-Macías Gabriela, Mena-Durán Armando, Pérez-Encinas Manuel M, Arce-Fernández Olga, Cuello Rebeca, Sánchez-García Joaquín, Gómez-Casares María T, Chillón María C, Calasanz María J, Ayala Rosa, Rodriguez-Veiga Rebeca, Barragán Eva, Montesinos Pau

Abstract excerpt

BACKGROUND: There are no studies assessing the evolution and patterns of genetic studies performed at diagnosis in acute myeloid leukemia (AML) patients. Such studies could help to identify potential gaps in our present diagnostic practices, especially in the context of increasingly complex procedures and classifications. METHODS: The REALMOL study (NCT05541224) evaluated the evolution, patterns, and clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to fms-Like Tyrosine Kinase 3

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Myeloid, Acute

Share to Nucleophosmin

Share to Registries

Share to Young Adult

Source

Open in PubMed

Identifiers

PMID: 38896056
DOI: 10.1002/cncr.35431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.PMID 38896056Read ↗

Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system.Semantic proximity Read ↗

Acute Myeloid Leukemia and Next-Generation Sequencing Panels for Diagnosis: A Comprehensive Review.Semantic proximity Read ↗

A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications.Semantic proximity Read ↗

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.Semantic proximity Read ↗

Genomics of Acute Myeloid Leukemia at Diagnosis and RemissionSemantic proximity Read ↗

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomesSemantic proximity Read ↗

Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.Semantic proximity Read ↗

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.Semantic proximity Read ↗

Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience.Semantic proximity Read ↗

Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.Semantic proximity Read ↗

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Semantic proximity Read ↗

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.